This approach moves treatment away from one-size-fits-all assumptions based on BMI and toward truly personalized medicine that accounts for how someone's body will likely respond
In a 72-week Zepbound (tirzepatide) study of adults with diabetes, average weight loss was 12.8% (28 lbs.) for 10 mg, 14.7% (33 lbs.) for 15 mg, and 3.2% (7 lbs.) for placebo
In two sensitivity analyses excluding phlebotomies less than 1 or 2 months apart, the magnitude of the effect size did not differ markedly from that of the primary analysis (data not shown)
These numbers describe reported experimental parameters in the research literature and are shared for research use only, not human application
Its likely her care plan included: Monitoring of hormone levels Medication adjustments Tailored nutrition advice Possibly discussions about FDA-approved weight loss tools This is an important reminder that personalized, supervised care is often key to sustainable results
And 39,000 different diets. But 5 pounds would come off and then invariably reappear, said Bucklew, 75, a public transit retiree in Ocean View, Del
